Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 101


Population-level associations between antiretroviral therapy scale-up and all-cause mortality in South Africa.

Larson E, Bendavid E, Tuoane-Nkhasi M, Mbengashe T, Goldman T, Wilson M, Klausner JD.

Int J STD AIDS. 2014 Aug;25(9):636-42. doi: 10.1177/0956462413515639. Epub 2013 Dec 18.


Population-level effect of HIV on adult mortality and early evidence of reversal after introduction of antiretroviral therapy in Malawi.

Jahn A, Floyd S, Crampin AC, Mwaungulu F, Mvula H, Munthali F, McGrath N, Mwafilaso J, Mwinuka V, Mangongo B, Fine PE, Zaba B, Glynn JR.

Lancet. 2008 May 10;371(9624):1603-11. doi: 10.1016/S0140-6736(08)60693-5.


Mass HIV Treatment and Sex Disparities in Life Expectancy: Demographic Surveillance in Rural South Africa.

Bor J, Rosen S, Chimbindi N, Haber N, Herbst K, Mutevedzi T, Tanser F, Pillay D, Bärnighausen T.

PLoS Med. 2015 Nov 24;12(11):e1001905; discussion e1001905. doi: 10.1371/journal.pmed.1001905. eCollection 2015 Nov.


Increases in pediatric antiretroviral treatment, South Africa 2005-2010.

Patel SD, Larson E, Mbengashe T, O'Bra H, Brown JW, Golman TM, Klausner JD.

PLoS One. 2012;7(9):e44914. doi: 10.1371/journal.pone.0044914. Epub 2012 Sep 13.


Effect of human immunodeficiency virus treatment on maternal mortality at a tertiary center in South Africa: a 5-year audit.

Black V, Brooke S, Chersich MF.

Obstet Gynecol. 2009 Aug;114(2 Pt 1):292-9. doi: 10.1097/AOG.0b013e3181af33e6.


Supporting the massive scale-up of antiretroviral therapy: the evolution of PEPFAR-supported treatment facilities in South Africa, 2005-2009.

Larson E, O'Bra H, Brown JW, Mbengashe T, Klausner JD.

BMC Public Health. 2012 Mar 9;12:173. doi: 10.1186/1471-2458-12-173.


Effectiveness of antiretroviral treatment in a South African program: a cohort study.

Fairall LR, Bachmann MO, Louwagie GM, van Vuuren C, Chikobvu P, Steyn D, Staniland GH, Timmerman V, Msimanga M, Seebregts CJ, Boulle A, Nhiwatiwa R, Bateman ED, Zwarenstein MF, Chapman RD.

Arch Intern Med. 2008 Jan 14;168(1):86-93. doi: 10.1001/archinternmed.2007.10.


Scale-up and continuation of antiretroviral therapy in South African treatment programs, 2005-2009.

Klausner JD, Serenata C, O'Bra H, Mattson CL, Brown JW, Wilson M, Mbengashe T, Goldman TM.

J Acquir Immune Defic Syndr. 2011 Mar 1;56(3):292-5. doi: 10.1097/QAI.0b013e3182067d99.


Adult mortality and antiretroviral treatment roll-out in rural KwaZulu-Natal, South Africa.

Herbst AJ, Cooke GS, Bärnighausen T, KanyKany A, Tanser F, Newell ML.

Bull World Health Organ. 2009 Oct;87(10):754-62.


The effect of antiretroviral therapy provision on all-cause, AIDS and non-AIDS mortality at the population level--a comparative analysis of data from four settings in Southern and East Africa.

Floyd S, Marston M, Baisley K, Wringe A, Herbst K, Chihana M, Kasamba I, Bärnighausen T, Urassa M, French N, Todd J, Zaba B.

Trop Med Int Health. 2012 Aug;17(8):e84-93. doi: 10.1111/j.1365-3156.2012.03032.x.


Estimation of adult antiretroviral treatment coverage in South Africa.

Adam MA, Johnson LF.

S Afr Med J. 2009 Sep;99(9):661-7.


Mortality among adults transferred and lost to follow-up from antiretroviral therapy programmes in South Africa: a multicenter cohort study.

Cornell M, Lessells R, Fox MP, Garone DB, Giddy J, Fenner L, Myer L, Boulle A; IeDEA-Southern Africa Collaboration.

J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):e67-75. doi: 10.1097/QAI.0000000000000269.


Mortality trends in the era of antiretroviral therapy: evidence from the Network for Analysing Longitudinal Population based HIV/AIDS data on Africa (ALPHA).

Reniers G, Slaymaker E, Nakiyingi-Miiro J, Nyamukapa C, Crampin AC, Herbst K, Urassa M, Otieno F, Gregson S, Sewe M, Michael D, Lutalo T, Hosegood V, Kasamba I, Price A, Nabukalu D, Mclean E, Zaba B; ALPHA Network.

AIDS. 2014 Nov;28 Suppl 4:S533-42. doi: 10.1097/QAD.0000000000000496.


Scaling up antiretroviral therapy in South Africa: the impact of speed on survival.

Walensky RP, Wood R, Weinstein MC, Martinson NA, Losina E, Fofana MO, Goldie SJ, Divi N, Yazdanpanah Y, Wang B, Paltiel AD, Freedberg KA; CEPAC-International Investigators.

J Infect Dis. 2008 May 1;197(9):1324-32. doi: 10.1086/587184.


The impact of HIV, an antiretroviral programme and tuberculosis on mortality in South African platinum miners, 1992-2010.

Lim MS, Dowdeswell RJ, Murray J, Field N, Glynn JR, Sonnenberg P.

PLoS One. 2012;7(6):e38598. doi: 10.1371/journal.pone.0038598. Epub 2012 Jun 22.


Determinants of the risk of dying of HIV/AIDS in a rural South African community over the period of the decentralised roll-out of antiretroviral therapy: a longitudinal study.

Mee P, Collinson MA, Madhavan S, Kabudula C, Gómez-Olivé FX, Kahn K, Tollman SM, Hargreaves J, Byass P.

Glob Health Action. 2014 Nov 20;7:24826. doi: 10.3402/gha.v7.24826. eCollection 2014.


Barriers to Care and 1-Year Mortality Among Newly Diagnosed HIV-Infected People in Durban, South Africa.

Bassett IV, Coleman SM, Giddy J, Bogart LM, Chaisson CE, Ross D, Flash MJ, Govender T, Walensky RP, Freedberg KA, Losina E.

J Acquir Immune Defic Syndr. 2017 Apr 1;74(4):432-438. doi: 10.1097/QAI.0000000000001277.


Trends in the burden of HIV mortality after roll-out of antiretroviral therapy in KwaZulu-Natal, South Africa: an observational community cohort study.

Reniers G, Blom S, Calvert C, Martin-Onraet A, Herbst AJ, Eaton JW, Bor J, Slaymaker E, Li ZR, Clark SJ, Bärnighausen T, Zaba B, Hosegood V.

Lancet HIV. 2017 Mar;4(3):e113-e121. doi: 10.1016/S2352-3018(16)30225-9. Epub 2016 Dec 10.


Monitoring the South African National Antiretroviral Treatment Programme, 2003-2007: the IeDEA Southern Africa collaboration.

Cornell M, Technau K, Fairall L, Wood R, Moultrie H, van Cutsem G, Giddy J, Mohapi L, Eley B, MacPhail P, Prozesky H, Rabie H, Davies MA, Maxwell N, Boulle A; International epidemiologic Databases to Evaluate AIDS Southern Africa Collaboration.

S Afr Med J. 2009 Sep;99(9):653-60.

Supplemental Content

Support Center